Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes.

Christof M Kazda,Juliana M Bue-Valleskey,Jenny Chien,Qianyi Zhang,Emmanuel Chigutsa,William Landschulz,Paula Wullenweber,Axel Haupt,Dominik Dahl

Diabetes care（2023）

引用 7|浏览5

暂无评分

摘要

Once-weekly BIF demonstrated noninferior glycemic control to once-daily degludec (treatment difference: 0.17% favoring degludec) and no difference in hypoglycemia or other safety findings in patients with T1D.

查看译文

关键词

insulin degludec,glycemic control,similar glycemic control,once-weekly

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要